Webinar Overview
“Biobanks have played a key role in the fight against Covid-19 by allowing researchers to access the samples they needed to study the disease and develop vaccines and treatments. While the pandemic presented a big challenge to the often-underfunded biobanks, it also provided an opportunity for growth in many other areas of research going forward.” (Carlos de Rojas, July 12, 2021, The Hidden Role of Biobanks in Covid-19 Research)
In achieving research growth, today’s Biobanks face ever increasing challenges in the form of more precise and consistent quality control, the need for training and streamlining of operations to produce that quality control, and the need for new revenue streams to support these enhanced operations. With Bruker's high-performance scientific instruments* and high-value analytical solutions, we are enabling Biobanks to breakthrough these barriers with a novel application that augments sample quality/validation, streamlines QC operations via automation, and provides a new Biobank revenue stream.
APRIL 26, 2023 - 5PM CEST | 11AM EDT
Key Learning Topics
- Increasing confidence in sample relevance via quality control.
- Understanding NMR* QC parameters and their meaning.
- Fully characterizing samples according to ISBER SPREC, focusing on pre and post-centrifugation delay characterization.
Please join us for a 60 min webinar to discuss these topics with Dr. Alexander M. Funk, Director of the Liquid Biobank and Magnetic Resonance Facility, Institute for Clinical Chemistry and Laboratory Medicine, University Hospital Dresden and Dr. Eduardo Nascimento, Bruker BioSpin Clinical Research Applications
Who should attend
Biobank Managers and Associated Principal Investigators interested in improving sample integrity, and by extension, study integrity of clinical trials and ongoing research.
*Bruker NMR Instruments are for Research Use Only and not for Use in Clinical Diagnostic Procedures
Speakers
Dr. Alexander M. Funk
Institute for Clinical Chemistry and Laboratory Medicine, University Hospital Dresden
Ph.D. Pedro Lopes
Field Application Scientist, Bruker BioSpin GmbH, Ettlingen
